FCF Software Venture Capital Monitor - Europe

The FCF Software Venture Capital Monitor – Europe is a monthly published overview focusing on the venture capital financing environment in the financial software, business/productivity software, entertainment software, educational software and other software related segments, displaying Venture capital financing trends in the European Software industry.

Key Findings of this FCF Software Venture Capital Monitor – Europe are:

  • In 2022, overall Software funding has reached EUR 20,588m so far
  • Top 5 Deals exceed EUR 480m each, largest transaction amounted to EUR 884m in Checkout.com (United Kingdom)
  • Blackstone (United States) dominates the Top 5 Investors (by deal volume), followed by Insight Partners (United States) and Tiger Global Management (United States)
  • Financial Software received 46% of the total investment volume
  • Financial Software and Business/Productivity Software are the sectors with the largest Investment activity

Key Findings of this FCF LSoftware Venture Capital Monitor – Europe are:

  • In 2022, overall Software funding has reached EUR 20,588m so far
  • Top 5 Deals exceed EUR 480m each, largest transaction amounted to EUR 884m in Checkout.com (United Kingdom)
  • Blackstone (United States) dominates the Top 5 Investors (by deal volume), followed by Insight Partners (United States) and Tiger Global Management (United States)
  • Financial Software received 46% of the total investment volume
  • Financial Software and Business/Productivity Software are the sectors with the largest Investment activity

Quoted in the Press

FCF Life Sciences in the Börse Online magazine | 19. April 2021

FCF Life Sciences in the Börse Online magazine | 19. April 2021 The Life Sciences team at FCF Fox Corporate Finance has recently published an analysis on Special Purpose Acquisition Companies (SPACs) with a focus on healthcare, among others, in the Börse Online magazine. The analysis includes the number and volume of healthcare SPAC IPOs to date, as well as the share price performance of healthcare companies already acquired by SPACs. FCF concludes that the companies’ stock prices have increased on average by 12% since the acquisition was announced. For more information, please check out the recently published FCF Life

Read More »
Press Release

FCF Life Sciences: Boom Bei Healthcare-SPACS Ungebrochen | GoingPublic 13.04.2021

Der Boom um Special Purpose Acquisition Companies, auch SPACs genannt, setzt sich 2021 ungebremst fort. Lag die Zahl der SPAC-Börsengänge im gesamten Jahr 2020 noch bei 306 SPAC-IPOs, liegt sie in den ersten drei Monaten dieses Jahres bereits bei 246. Von Dr. Mathias Schott und Alexander Kuhn „2021 wird das Jahr der SPACs. Gerade für kosten- und forschungsintensive Healthcare-Unternehmen bieten SPACs einen schnellen und effizienten Weg an die Börse und zu notwendiger Liquidität“, sagt Dr. Mathias Schott, Leiter von FCF Life Sciences. So steigt die Zahl der SPAC-Börsengänge mit Fokus auf den Healthcare-Bereich bereits jetzt sprunghaft an: Nach 78 IPOs

Read More »

Capital Markets Research

We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our research focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:

NEWS

[a-zA-Z0-9_.-]
[a-zA-Z0-9_.-]
[a-zA-Z0-9]
[a-zA-Z0-9]